13FAI ai-powered hedge fund tracker

CVS HEALTH CORP (CVS) — Hedge Fund Ownership Q4 2025

CVS
Q4 2025Q3 2025Q2 2025Q1 2025
# Fund % of Portfolio † Shares † Shares vs Prior Quarter † Shares vs Prior Year † Aggregate Value † Reported Price * Option
1
Fairfax Financial Holdings
Prem Watsa
10.33% 2.7M $215.2M $79.35
2
Davis Selected Advisers
Christopher Davis
4.55% 12.8M +11.90% +12.07% $1.01B $79.36
3
Patient Capital Management
Samantha McLemore
3.77% 1.2M -0.68% -5.16% $97.7M $79.36
4
Pzena Investment Management
Richard Pzena
3.70% 15.6M -1.66% -20.55% $1.24B $79.36
5
Hillman Capital Management
Mark Hillman
3.58% 72K -12.96% -40.08% $5.7M $79.36
6
Dodge & Cox
2.68% 62.5M -14.58% -10.83% $4.96B $79.36
7
Olstein Capital Management
Robert Olstein
0.91% 56K -18.84% -54.47% $4.4M $79.36
8
Ariel Investments
0.71% 825K -16.63% -11.15% $65.5M $79.36
9
Third Avenue Management
0.08% 12K +16.68% $959,066 $79.36
10
Tweedy, Browne
Tweedy, Browne Co LLC
0.08% 12K +16.68% $959,066 $79.36
11
Matrix Asset Advisors
David Katz
0.04% 6K -0.03% $490,048 $79.36
11 Total 95.8M -9.25% -9.91% $7.60B
* Reported price is not an actual purchase or sale price. It is the price as of the last portfolio date.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.